possessions. All five judges accepted that the A1P1 rights of compensators and insurers were engaged by the Bill, since their possessions in the form of capital funds would be directly impacted by having to make payments in respect of NHS charges. The question then became whether this interference with property rights could be justified. Lord Mance identified four stages in the process of review of legislative measures which engage A1P1:
Whether there is a legitimate aim which could justify a restriction of the relevant protected right;
(ii)
Whether the measure adopted is rationally connected to that aim;
(iii) Whether the aim could have been achieved by a less intrusive measure;
(iv) Whether, on a fair balance, the benefits of achieving the aim by the measure outweigh the disbenefits resulting from the restriction of the relevant protected right.
He stressed that the court will accept the legislature's judgment as to the existence of a legitimate aim at stage (i) review, unless that judgment is manifestly without reasonable foundation.
However, this latitude does not extend to stage (iv), where the level of scrutiny required by the Court is higher. The question at stage (iv) is whether the measure achieves a fair and proportionate balance between the public interest pursued and the private interests affected. Although the views of the legislature may still carry significant weight in the balancing exercise, private interests must be given similar consideration, and the court may be particularly well placed to evaluate those in the context of a particular case. The consultation paper suggests a Bill written in terms which closely mirror the Welsh legilsationproposal, with a direct obligation on compensators to pay NHS charges and a specific statutory extension of insurance cover in relation to these costs.
Given the findings of the Supreme Court outlined above, an A1P1 challenge to any Bill which results seems inevitable. Some of the concerns that animated the majority in carrying out the balancing exercise -in particular, the very short transitional period proposed prior to the introduction of the legislation, which gave insurers little time to adjust -could certainly be ameliorated in Scotland. However, so long as any legislation is conceptualised as placing significant new liabilities on compensators and insurers, it will be difficult for it to satisfy the proportionality test. The alternative interpretation put forward by the minority, although interesting, is hard to see as anything other than a back-formation. For all that the Bill could be construed in some sense as removing a benefit, the words speak clearly of imposing a liability. Legislation which actually imposed liability for NHS charges on sufferers of asbestos-related diseases, even if made subject to the ability of sufferers to recover from compensators, would give rise to A1P1 issues of its own, in addition to being a deeply unattractive proposition for anyone who values the current model of the NHS as a service free at the point of use.
Of course, sufferers of asbestos-related diseases, along with all other working people in the UK, have already paid for NHS treatment through income tax and national insurance. In identifying the beneficiary of the Welsh Bill as "the state", it is perhaps easy to lose sight of the fact that the state includes all of us who pay or have paid into the public coffers over the years. A bigger question arises 22 Para 139. 23 Consultation on the Proposed Recovery of Medical Costs for Asbestos Diseases (Scotland) Bill, p1.
